Dual antiplatelet therapy (PEGASUS) vs. dual pathway (COMPASS): a head-to-head in vitro comparison
No. | 84 |
---|---|
Citation | Platelets. Apr 15:1-6 (2021) |
Institute | University of Ottawa Heart Institute, Canada |
1st Author | CR Clifford |
AR | 〇 |
PL | 〇 |
HD | |
Paper types | Basic research |
Main purpose | Provide a first in vitro comparison of DAPT versus Dual Pathway(DP) approach at clinically proven doses |
Disease | |
Antiplatelet drug | aspirin, ticagrelor |
Anticoagulant drug | rivaroxaban |
Other drug | |
Clinical specimens | |
Animal | |
Keyword | Direct oral anticoagulants; dual antiplatelet therapy; myocardial infarction; percutaneous coronary intervention; total thrombus analysis system |